Andresen Reimer, Radmer Sebastian, Andresen Julian Ramin, Wollny Mathias, Nissen Urs, Schober Hans-Christof
Institut für Diagnostische und Interventionelle Radiologie/Neuroradiologie, Westküstenklinikum Heide, Akademisches Lehrkrankenhaus der Universitäten Kiel, Lübeck und Hamburg.
Facharztpraxis für Orthopädie, Zentrum für Bewegungsheilkunde, Berlin.
Z Orthop Unfall. 2019 Oct;157(5):524-533. doi: 10.1055/a-0815-5073. Epub 2019 Feb 8.
The objective of this study was a comparative analysis of cement augmentation by means of RFS and CSP with regard to outcome and cost-effectiveness.
CT-guided cement augmentation was performed on 100 patients with a total of 168 non-dislocated insufficiency fractures, 50 patients being treated with RFS and 50 patients with CSP. Leakages were detected by CT. Pain intensity was determined on a VAS before and after the intervention. The patients' self-sufficiency was assessed using the Barthel index. Patients were asked about any complications and their level of satisfaction. Costs incurred for carrying out the procedure were compared with the respective reimbursements received.
Both procedures were technically fully feasible. No leakages were found in the RFS group, as opposed to 8.1% asymptomatic leakages in the CSP group. The mean value for pain before intervention was 8.8 in the RFS group and 8.7 in the CSP group. On the second postoperative day, there was a significant pain reduction with a value of 2.4 for both groups, which remained more or less constant over the follow-up period. The Barthel index increased significantly from an average of 30 before the intervention to 80 on the fourth postoperative day and 70 after 24 months. No differences were found between the two procedures with regard to pain, improvement in functional status and satisfaction. Taking into account the state-wide base rate used for calculating reimbursement, 3,834.75 € remained for RFS and 5,084.32 € for CSP.
RFS and CSP are minimally invasive procedures that achieve equally good and sustained pain reduction, leading to markedly improved self-sufficiency of the patients. With regard to possible cement leakages, RFS is the safer method. A profit can be generated with both techniques.
本研究的目的是对采用RFS和CSP进行骨水泥强化在疗效和成本效益方面进行比较分析。
对100例共168处非脱位性骨质疏松性骨折患者进行CT引导下骨水泥强化治疗,其中50例采用RFS治疗,50例采用CSP治疗。通过CT检测渗漏情况。在干预前后采用视觉模拟评分法(VAS)测定疼痛强度。使用Barthel指数评估患者的自理能力。询问患者有无并发症及其满意度。将实施该手术的费用与各自获得的报销费用进行比较。
两种手术在技术上均完全可行。RFS组未发现渗漏,而CSP组有8.1%的无症状渗漏。RFS组干预前疼痛平均值为8.8,CSP组为8.7。术后第二天,两组疼痛均显著减轻,数值均为2.4,在随访期内基本保持不变。Barthel指数从干预前的平均30显著提高到术后第四天的80和24个月后的70。在疼痛、功能状态改善和满意度方面,两种手术之间未发现差异。考虑到用于计算报销的全州基准费率,RFS剩余3834.75欧元,CSP剩余5084.32欧元。
RFS和CSP均为微创手术,在减轻疼痛方面效果相当且持续,能显著提高患者的自理能力。就可能的骨水泥渗漏而言,RFS是更安全的方法。两种技术均可产生利润。